Oncology Reports

Oncology Reports

肿瘤学报告

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Oncology Reports》是由Spandidos Publications出版社于1994年创办的英文国际期刊(ISSN: 1021-335X,E-ISSN: 1791-2431),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.4713...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比77.16%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在162篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Oncology Reports审稿周期约为 约5.5月 。该刊近年被列入国际预警名单,年发文量约162篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 162 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 102 / 322

68.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 100 / 322

69.1%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:8.5 SJR:0.864 SNIP:0.719
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 74 / 404

81%

大类:Medicine 小类:Cancer Research Q2 67 / 230

71%

期刊发文

  • Anticancer effects and mechanisms of astragaloside-IV

    Author: Zhou, Liangxing; Li, Mengpeng; Chai, Zhengbin; Zhang, Junli; Cao, Kuan; Deng, Lei; Liu, Yanming; Jiao, Cun; Zou, Gang-Ming; Wu, Jibiao; Han, Fabin

    Journal: ONCOLOGY REPORTS. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.3892/or.2022.8442

  • Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis

    Author: Zhao, Yu; Ren, Pengpeng; Yang, Zhiqin; Wang, Lei; Hu, Changhua

    Journal: ONCOLOGY REPORTS. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.3892/or.2022.8453

  • Prostate cancer cell-derived spondin 2 boosts osteogenic factor levels in osteoblasts via the PI3K/AKT/mTOR pathway

    Author: Wang, Hongbo; Zhang, Ming; Lu, Wencheng; Yuan, Chao

    Journal: ONCOLOGY REPORTS. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.3892/or.2022.8460

  • Biochemical and clinical effects of RPS20 expression in renal clear cell carcinoma

    Author: Shen, Cheng; Chen, Zhan; Zhang, Yong; Xu, Wei; Peng, Rui; Jiang, Jie; Zuo, Wenjing; Fan, Yihui; Zheng, Bing

    Journal: ONCOLOGY REPORTS. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.3892/or.2022.8459

  • Research progress on the circRNA-mediated regulation of tumor angiogenesis through ceRNA mechanisms

    Author: Meng, Dandan; Jia, Ruixue; Yuan, Shun; Wei, Mengjuan; Bao, Xingxun; Zhu, Chengfeng; Wang, Wantao; Li, Zongxin

    Journal: ONCOLOGY REPORTS. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.3892/or.2022.8449

  • DPP3 expression promotes cell proliferation and migration in vitro and tumour growth in vivo, which is associated with poor prognosis of oesophageal carcinoma

    Author: Liu, Jing-Kun; Abudula, Abulizi; Yang, Hai-Tao; Xu, Li-Xiu; Nuerrula, Yiliyaer; Bai, Ge; Tulahong, Aisiker; Eli, Maynur

    Journal: ONCOLOGY REPORTS. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.3892/or.2022.8446

  • CD14, a novel surface marker of esophageal cancer stem cells

    Author: Lin, Yonggang; Dong, Jianjiang; Yu, Wei; Li, Yufei; Liu, Zhixin; Liu, Jiaqi; Wang, Cuiju; Qin, Jian; Zhu, Liting; Liang, Jun

    Journal: ONCOLOGY REPORTS. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.3892/or.2022.8450

  • MicroRNAs as early diagnostic biomarkers for non-small cell lung cancer (Review)

    Author: Liang, Xindi; Wu, Qiang; Wang, Yuan; Li, Shirong

    Journal: ONCOLOGY REPORTS. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.3892/or.2022.8445